恩华药业跌2.09%，成交额1.90亿元，主力资金净流出614.35万元

Core Points - Enhua Pharmaceutical's stock price decreased by 2.09% on October 10, trading at 27.21 CNY per share with a total market capitalization of 27.64 billion CNY [1] - The company has seen a year-to-date stock price increase of 13.42%, with a recent decline of 5.19% over the last five trading days [1] Financial Performance - For the first half of 2025, Enhua Pharmaceutical reported a revenue of 3.01 billion CNY, representing a year-on-year growth of 8.93%, and a net profit attributable to shareholders of 700 million CNY, up 11.38% year-on-year [2] - Cumulative cash dividends since the company's A-share listing amount to 1.577 billion CNY, with 890 million CNY distributed over the last three years [3] Shareholder Information - As of June 30, 2025, the number of shareholders increased by 30.17% to 43,600, while the average circulating shares per person decreased by 23.19% to 20,209 shares [2] - The top ten circulating shareholders include the Southern CSI 500 ETF, which is a new entrant holding 9.0517 million shares [3]